603168.SH
Zhejiang Shapuaisi Pharmaceutical Co. Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 5.54
−0.72%Year over year
Reported trailing growth
- Revenue
- +2.6%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +7.6%
- Operating cash flow
- +59.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.6%
- EBITDA
- —
- EBIT
- —
- Net income
- -93.4%
- EPS
- -93.9%
- Free cash flow
- +51.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026